MDM2 Inhibitor, Nutlin 3a, Induces P53 Dependent Autophagy in Acute Leukemia by AMP Kinase Activation

PLoS ONE - United States
doi 10.1371/journal.pone.0139254
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Cellular Quiescence Caused by the Mdm2 Inhibitor Nutlin-3a

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2009English

Activation of the P53 Pathway by the MDM2 Inhibitor Nutlin-3a Overcomes BCL2 Overexpression in a Preclinical Model of Diffuse Large B-Cell Lymphoma Associated With T(14;18)(q32;q21)

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Activation of AMP-activated Protein Kinase Induces P53-Dependent Apoptotic Cell Death in Response to Energetic Stress

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

A Plant Triterpenoid, Avicin D, Induces Autophagy by Activation of AMP-activated Protein Kinase

Cell Death and Differentiation
Cell BiologyMolecular Biology
2007English

Alpha Ketoglutarate Levels, Regulated by P53 and OGDH, Determine Autophagy and Cell Fate/Apoptosis in Response to Nutlin-3a

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2018English

P53 Mediated Death of Cells Overexpressing MDM2 by an Inhibitor of MDM2 Interaction With P53

Oncogene
Cancer ResearchGeneticsMolecular Biology
1999English

A Novel Combination Therapy Approach for the Treatment of Acute Myeloid Leukemia: The Multi-Kinase Inhibitor Sorafenib and the HDM2 Inhibitor Nutlin-3

Haematologica
Hematology
2012English

Pharmacologic Activation of P53 by Small-Molecule MDM2 Antagonists

Current Pharmaceutical Design
Drug DiscoveryPharmacology
2011English

P53-Mdm2 Pathway: Evidences for a New Targeted Therapeutic Approach in B-Acute Lymphoblastic Leukemia

Frontiers in Pharmacology
Pharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy